Total Funding
95
93
Total FundingPost-IPO Debt raised
Growth Score
-2 pts
Heat Score
16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
6942
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
- David Hung: Founder, President, and Chief Executive OfficerPast Role: Medivation, Founder, President, and CEO
Gary Hattersley: Chief Scientific OfficerPast Role: Genetics Institute, Held Positions
About the Company
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology. It engages in treating patients with the most difficult-to-treat cancers for which conventional therapies have failed.
